Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Neural Therapeutics Inc. ( (TSE:NURL) ) has provided an announcement.
Neural Therapeutics Inc. has announced two significant developments to enhance its ethnobotanical strategy. The company has secured a research agreement with Peru’s national forestry authority, SERFOR, to continue its research on mescaline-producing plants, a step that underscores its commitment to regulatory compliance and ethical research. Additionally, Neural’s German partner, CWE European Holdings Inc., has obtained exclusive rights to distribute Ritual Herbs, a premium line of herbal smoking blends in Germany, capitalizing on the growing market for natural, nicotine-free smoking alternatives.
More about Neural Therapeutics Inc.
Neural Therapeutics Inc. is an ethnobotanical drug discovery company that focuses on developing therapeutic drugs for mental illnesses related to substance use disorders.
Average Trading Volume: 49,913
Learn more about NURL stock on TipRanks’ Stock Analysis page.